Latest anaphylaxis Stories
Knowledge gaps especially apparent for primary care and emergency physicians, often on front line in treatment for anaphylaxis WASHINGTON, Jan.
New review outlines the data supporting the relationship between urate-lowering efficacy and the risk for infusion reactions with Krystexxa® (pegloticase), the only FDA-approved treatment for chronic
Food allergies can drain the thrill out of Thanksgiving eating, but AllergyEasy sublingual drops can help.
Research funded by Penland Foundation, Houston Independent School District and Texas Children's Hospital provides food allergy preparedness education HOUSTON, Nov.
EpiPen® Auto-Injector Locations Designated on Updated Guide Maps and Signage PITTSBURGH, Nov. 7, 2014 /PRNewswire/ -- Mylan Inc.
VIENNA, Va., Oct. 31, 2014 /PRNewswire-USNewswire/ -- Allergy & Asthma Network, a leading nonprofit patient education and advocacy organization, today commended New York Gov.
Survey Findings Reveal Incidence of First-Time Reactions in School Setting PITTSBURGH, Oct.
In the news release, Comprehensive Study of Allergic Deaths in U.S.
Montefiore/Einstein Research Indicates Higher Prevalence Among Older People and African-Americans BRONX, N.Y., Sept.
The $255,000 award will help ITI conduct vaccine validation studies over one year Hershey, PA & Rockville, MD (PRWEB) September 17, 2014 Immunomic
The inchman (Myrmecia forficate) is a species of bull ant that can be found in Australia, in a range that includes Tasmania and possibly southeastern areas of Australia. This species is gregarious, living in colonies like most other ant species, but it forages for food alone. Nests often go unseen and are typically found under rocks.Â It reaches an average body length of up to one inch long, the trait from which it received its common name. The inchman is both a scavenger and a...
- totally perplexed and mixed up.